Johnson & Johnson (JNJ) Tops Q2 EPS by 9c, Beats on Revenue; Offers Strong FY25 Guidance
Tweet
Share
E-mail
Get Alerts JNJ Hot Sheet
Price: $269.47 -0.19%
Revenue Growth %: +5.6%
Financial Fact:
Other (income) expense, net: -54M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +5.6%
Financial Fact:
Other (income) expense, net: -54M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Johnson & Johnson (NYSE: JNJ) reported Q2 EPS of $2.77, $0.09 better than the analyst estimate of $2.68. Revenue for the quarter came in at $23.74 billion versus the consensus estimate of $22.86 billion.
GUIDANCE:
Johnson & Johnson sees FY2025 EPS of $10.63-$10.73, versus the consensus of $10.61. Johnson & Johnson sees FY2025 revenue of $93.2-93.6 billion, versus the consensus of $91.3 billion.
For earnings history and earnings-related data on Johnson & Johnson (JNJ) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GameStop CEO Cohen buys 1.15M shares
- Adeptus Biotechnologies Corp. (ADPT) PT Raised to $34 at BTIG
- Brookfield prices $600M senior notes at 5.65% due 2031
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
